That actually gives me hope about CD12 results. They did not exclude other therapeutics either. One thing that worried me was if the other drugs would downgrade LLs effect such as SAEs etc. and affect statistical significance. Our interim results will be out soon. The question is: what drug is speedier/has better efficacy/is cheaper?